Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 Shiv Kumar SarinChandan Kumar Kedarisettythe APASL ACLF Working Party Guidelines 26 September 2014 Pages: 453 - 471
Assessment of diastolic function in the management of patients with cirrhosis Søren Møller Editorial 27 July 2014 Pages: 472 - 474
The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis Richard Moreau Editorial 06 September 2014 Pages: 475 - 477
Community-based hepatitis B screening: what works? Monica C. RobotinJacob George Review Article Open access 01 August 2014 Pages: 478 - 492
Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis Francesco BertagnaMattia BertoliGiorgio Treglia Review Article 03 September 2014 Pages: 493 - 500
Real-life practice of antiviral therapy and disease patterns of patients with chronic hepatitis B: a single-center retrospective observation study Yusheng JieXiangyong LiYutian Chong Original Article 23 July 2014 Pages: 501 - 507
Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China Guifeng YangMeifang HanZhanhui Wang Original Article 31 July 2014 Pages: 508 - 516
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial Mitchell L. ShiffmanHugo CheinquerStefan Zeuzem Original Article 24 July 2014 Pages: 517 - 526
The natural history of HCV-related cirrhosis and its temporal progression across the different clinical stages Eduardo Vilar GomezLuis Calzadilla BertotAli Yasells Garcia Original Article 23 August 2014 Pages: 527 - 539
Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks Nghia H. NguyenShelley A. McCormackMindie H. Nguyen Original Article 06 September 2014 Pages: 540 - 549
Assessment of the features of serum apolipoprotein profiles in chronic HCV infection: difference between HCV genotypes 1b and 2 Nobuyoshi SekiTomonori SugitaYoshio Aizawa Original Article 26 September 2014 Pages: 550 - 559
Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C Shivakumar NarayananKerry TownsendAnu Osinusi Original Article 21 September 2014 Pages: 560 - 566
Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma Ying SunDong XiQin Ning Original Article Open access 25 September 2014 Pages: 567 - 575
Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis Giovanna FerraioliCarmine TinelliCarlo Filice Original Article 20 September 2014 Pages: 576 - 581
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study Min Jae KimKyoung-Ho SongNam Joong Kim Original Article 08 June 2014 Pages: 582 - 587
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis Dimitrios S. KaragiannakisJiannis VlachogiannakosSpiros D. Ladas Original Article 08 June 2014 Pages: 588 - 594
Erratum to: Yttrium-90 radioembolization for hepatocellular carcinoma in hepatitis B: commentary on a 103-patient Asian cohort Laura KulikRiad Salem Erratum 20 September 2014 Pages: 595 - 595
